Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Wolfsegger

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Statistics in Medicine|December 5, 2013
Authors' reply to Comments on 'Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs"Thomas Jaki, Philip Pallmann, Martin J Wolfsegger
Journal of Biopharmaceutical Statistics|May 25, 2010
Establishing bioequivalence in complete and incomplete data designs using AUCsThomas Jaki, Martin J Wolfsegger, John-Philip Lawo
Biometrics|February 28, 2014
A hybrid method to estimate the minimum effective dose for monotone and non-monotone dose-response relationshipsMartin J Wolfsegger, Georg Gutjahr, Werner Engl, et al.
Toxicology and Applied Pharmacology|June 23, 2009
A note on statistical analysis of organ weights in non-clinical toxicological studiesMartin J Wolfsegger, Thomas Jaki, Barbara Dietrich, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 10, 2013
A comparison of methods for classifying samples as truly specific with confirmatory immunoassaysThomas Jaki, John-Philip Lawo, Martin J Wolfsegger, et al.
Pharmaceutical Statistics|March 17, 2026
Paired and AB/BA Cross-Over Design in Early Phase Clinical Trials: A Closer Look at Within-Subject Variance BiasMartin J Wolfsegger, Peixin Xu, Amy Cotterill, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 13, 2011
A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassaysThomas Jaki, John-Philip Lawo, Martin J Wolfsegger, et al.
American Journal of Obstetrics and Gynecology|September 3, 2010
Two-component polyethylene glycol surgical sealant influence on intraperitoneal infection in a refined rodent modelKathleen E Rodgers, Florence G Burleson, Gary R Burleson, et al.
Pharmaceutical Statistics|October 16, 2020
Assessing goodness-of-fit for evaluation of dose-proportionalityMartin J Wolfsegger, Alexander Bauer, Detlew Labes, et al.
Blood|December 18, 2012
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patientsShawn F J Whelan, Christoph J Hofbauer, Frank M Horling, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Statistics in Medicine|December 5, 2013
Authors' reply to Comments on 'Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs"Thomas Jaki, Philip Pallmann, Martin J Wolfsegger
Journal of Biopharmaceutical Statistics|May 25, 2010
Establishing bioequivalence in complete and incomplete data designs using AUCsThomas Jaki, Martin J Wolfsegger, John-Philip Lawo
Biometrics|February 28, 2014
A hybrid method to estimate the minimum effective dose for monotone and non-monotone dose-response relationshipsMartin J Wolfsegger, Georg Gutjahr, Werner Engl, et al.
Toxicology and Applied Pharmacology|June 23, 2009
A note on statistical analysis of organ weights in non-clinical toxicological studiesMartin J Wolfsegger, Thomas Jaki, Barbara Dietrich, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 10, 2013
A comparison of methods for classifying samples as truly specific with confirmatory immunoassaysThomas Jaki, John-Philip Lawo, Martin J Wolfsegger, et al.
Pharmaceutical Statistics|March 17, 2026
Paired and AB/BA Cross-Over Design in Early Phase Clinical Trials: A Closer Look at Within-Subject Variance BiasMartin J Wolfsegger, Peixin Xu, Amy Cotterill, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 13, 2011
A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassaysThomas Jaki, John-Philip Lawo, Martin J Wolfsegger, et al.
American Journal of Obstetrics and Gynecology|September 3, 2010
Two-component polyethylene glycol surgical sealant influence on intraperitoneal infection in a refined rodent modelKathleen E Rodgers, Florence G Burleson, Gary R Burleson, et al.
Pharmaceutical Statistics|October 16, 2020
Assessing goodness-of-fit for evaluation of dose-proportionalityMartin J Wolfsegger, Alexander Bauer, Detlew Labes, et al.
Blood|December 18, 2012
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patientsShawn F J Whelan, Christoph J Hofbauer, Frank M Horling, et al.
Pageof 2